Zobrazeno 1 - 10
of 153
pro vyhledávání: '"William H Yang"'
Publikováno v:
PLoS ONE, Vol 12, Iss 8, p e0183869 (2017)
Omalizumab is a non-steroidal medication indicated for the treatment of poorly controlled moderate-to-severe allergic asthmatics. This observational study examines the "real world" effectiveness of omalizumab in this population.This is a one year ope
Externí odkaz:
https://doaj.org/article/601a8f10052445dfb451910918025c0d
Autor:
William H Yang, Jerry Dolovich, Michel A Drouin, Paul Keith, Jennifer Haddon, Barbara Jennings, the Rhinocort Study Group
Publikováno v:
Canadian Respiratory Journal, Vol 5, Iss 6, Pp 455-460 (1998)
OBJECTIVE: To compare the effect of budesonide Turbuhaler 400 µg/day with budesonide aqua 256 µg/day in the treatment of seasonal allergic rhinitis (SAR). Secondarily to ascertain patients' preferences for the two nasal devices and to assess qualit
Externí odkaz:
https://doaj.org/article/f6bfb8d8786f448caee7f6eae0fcdaff
Autor:
Kasey Price, William H. Yang, Leticia Cardoso, Chiung-Min Wang, Richard H. Yang, Wei-Hsiung Yang
Publikováno v:
Cancers, Vol 16, Iss 5, p 1000 (2024)
The AP-1 protein complex primarily consists of several proteins from the c-Fos, c-Jun, activating transcription factor (ATF), and Jun dimerization protein (JDP) families. JDP2 has been shown to interact with the cAMP response element (CRE) site prese
Externí odkaz:
https://doaj.org/article/7578a44f00f945a3ad62ac749e6c0ca8
Autor:
William H. Yang, Andrew P. George, Chiung-Min Wang, Richard H. Yang, Avery M. Duncan, Darshti Patel, Zachery D. Neil, Wei-Hsiung Yang
Publikováno v:
Current Oncology, Vol 30, Iss 2, Pp 1614-1625 (2023)
The programmed cell death protein 4 (PDCD4), a well-known tumor suppressor, inhibits translation initiation and cap-dependent translation by inhibiting the helicase activity of EIF4A. The EIF4A tends to target mRNAs with a structured 5′-UTR. In add
Externí odkaz:
https://doaj.org/article/d1bc976f919b48bfa7913cf88b2b5afc
Autor:
Timothy J Craig, Avner Reshef, H Henry Li, Joshua S Jacobs, Jonathan A Bernstein, Henriette Farkas, William H Yang, Erik S G Stroes, Isao Ohsawa, Raffi Tachdjian, Michael E Manning, William R Lumry, Inmaculada Martinez Saguer, Emel Aygören-Pürsün, Bruce Ritchie, Gordon L Sussman, John Anderson, Kimito Kawahata, Yusuke Suzuki, Petra Staubach, Regina Treudler, Henrike Feuersenger, Fiona Glassman, Iris Jacobs, Markus Magerl
Publikováno v:
The Lancet. 401:1079-1090
Autor:
Timothy Craig, Avner Reshef, Huamin Henry Li, Joshua S. Jacobs, Jonathan A. Bernstein, Henriette Farkas, William H. Yang, Erik Stroes, Isao Ohsawa, Raffi Tachdjian, Michael E. Manning, William R. Lumry, Inmaculada Martinez Saguer, Emel Aygören-Pürsün, Bruce Ritchie, Gordon L. Sussman, John Anderson, Kimito Kawahata, Yusuke Suzuki, Petra Staubach, Regina Treudler, Henrike Feuersenger, Fiona Glassman, Iris Jacobs, Markus Magerl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::08ef1a615b3d0e2b213435ca175bf48e
https://doi.org/10.2139/ssrn.4336148
https://doi.org/10.2139/ssrn.4336148
Autor:
Holly J. Clarke, William H. Yang, Timothy T. Lu, Joshua Galanter, Petra Staubach, Tonny Tanus, Tracy Burgess, Gordon Sussman, Jeremy J. Lim, Leslie W. Chinn, Remi Gagnon, D. James Haddon, Tom Chu, Marcus Maurer, Anastasia Teterina, Martin Metz
Publikováno v:
Nature Medicine. 27:1961-1969
Bruton’s tyrosine kinase (BTK) is crucial for FceRI-mediated mast cell activation and essential for autoantibody production by B cells in chronic spontaneous urticaria (CSU). Fenebrutinib, an orally administered, potent, highly selective, reversibl
Autor:
William H. Yang, Wei-Hsiung Yang
Publikováno v:
Cancer Research. 83:3735-3735
Cancer is one of the most dreaded diseases of the 21st century for humans. Currently, the human cancer mortality rate is approximately 11-25%. However, for some animals, such as elephants, the cancer mortality rate is lower than 5%. p53 is a signific
Autor:
Andreas Maronna, Kirsten Beyer, Dianne E. Campbell, Todd D. Green, Roxanne C. Oriel, Romain Lambert, Doris Staab, Stephanie A. Leonard, Jonathan O'b Hourihane, Matthew Greenhawt, William H. Yang, Aurélie Peillon, Hugh A. Sampson, Peter K. Smith, Michael O'Sullivan, Sharon Chinthrajah, Terri F. Brown-Whitehorn, Amal Assa'ad, Gordon Sussman, Vera Mahler, J. Andrew Bird, Lars Lange, Hey Jin Chong, Sara Anvari, Philippe Bégin, Robert J. Wood, Daniel Petroni, Anna Nowak-Wegrzyn, Edmond S. Chan, Remi Gagnon, Wayne G. Shreffler, Carla M. Davis, Bruce J. Lanser, David Fleischer, Lara S. Ford, Jacqueline A. Pongracic, Lynda C. Schneider, Aideen Byrne, Susan L. Prescott, Amarjit Cheema, Stacie M. Jones, Edwin H. Kim, Timothée Bois
Publikováno v:
Journal of Allergy and Clinical Immunology. 146:863-874
Background The PEPITES (Peanut EPIT Efficacy and Safety) trial, a 12-month randomized controlled study of children with peanut allergy and 4 to 11 years old, previously reported the safety and efficacy of epicutaneous immunotherapy (EPIT) for peanut
Autor:
William H. Yang, Suzanne Kelly, Laura Haya, Rym Mehri, Divya Ramesh, Michelle DeVeaux, Claire Q. Wang, Pretty Meier, Sumit Narula, Furat Shawki, Ryan Pennington, Lorah Perlee, Meagan P. O’Brien
Publikováno v:
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology. 52(2)
To determine the proportion and reproducibility of cat-allergic mild asthmatics with early asthmatic response (EAR) during cat allergen exposure in a naturalistic exposure chamber (NEC).This was a prospective, observational study in 30 cat-allergic m